LHW-090

N/A

Report date: 2023/10/11 20:43:10
NME

Base Information

Drug NameLHW-090
Drug Alias NameLHW-090LHV-527
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeprilysin inhibitors
TargetsNeprilysin
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A